Novo Warns Of Steep Sales Decline In 2026, Blames US Price Cuts

 
• By Andrew McConaghie
  
Novo Nordisk And India's Emcure Have Struck A Deal For GLP-1 Semaglutide Wegovy
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business